Concerning the CYP17 MspA1 polymorphism and breast cancer risk: a meta-analysis

Mutagenesis. 2002 Sep;17(5):445-6; author reply 447-8. doi: 10.1093/mutage/17.5.445.
No abstract available

Publication types

  • Comparative Study
  • Letter
  • Comment

MeSH terms

  • Breast Neoplasms / enzymology
  • Breast Neoplasms / genetics*
  • Case-Control Studies
  • Disease Susceptibility
  • Female
  • Humans
  • Meta-Analysis as Topic
  • Odds Ratio
  • Polymorphism, Genetic*
  • Risk Factors
  • Steroid 17-alpha-Hydroxylase / genetics*

Substances

  • Steroid 17-alpha-Hydroxylase